Curis Hedgehog and Beyond --plus multi-targeting cancer inhibitors

Chronic Myeloid Leukemia (CML) Phase I
http://clinicaltrials.gov/ct2/show/NCT00953758?term=PF-04449913
This study examines the effect of a small molecule inhibitor to the Sonic Hedgehog pathway on select hematologic malignancies. Part two of the study will examine the effect of this inhibitor in combination with dasatinib.

Study Start Date: January 2010
Estimated Study Completion Date: April 2013


http://clinicaltrials.gov/ct2/results?term=PF-04449913